EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Sacral nerve stimulation modulates disease activity and autonomic function in active rheumatoid arthritis: a randomized pilot study

Xiaoqin Wang, Bingguo Xu, Guoxin Wang, Leilei Yang, Dinglei Su, Jiande D Z Chen

Clinical Rheumatology · 2026

DOI: 10.1007/s10067-026-08288-4 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Xiaoqin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autonomic Nervous System, Lumbosacral Plexus, Acupuncture Therapy. Die Arbeit nennt 34 Literaturangaben. Gefördert von: International Cooperation Project of Nanjing Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the feasibility and safety as well as potential effects of percutaneous sacral nerve stimulation (SNS) via acupuncture needles in patients with active rheumatoid arthritis (RA). METHODS: Twenty-one patients with active RA were allocated to receive either active SNS (n = 11) or sham stimulation (n = 10) for 60 min daily over 14 days. Primary outcomes were changes in disease activity, assessed by the Disease Activity Score in 28 joints (DAS-28), tender joint count (TJC), swollen joint count (SJC), pain intensity on a visual analogue scale (VAS), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Secondary outcomes included the following: (1) patient-reported outcomes for joint function, fatigue, anxiety, and depression; (2) serum levels of inflammatory cytokines; and (3) heart rate variability (HRV) parameters as a measure of autonomic function. RESULTS: In this pilot study, the SNS group showed significant within-group improvements in TJC, VAS, DAS28-ESR, and DAS28-CRP. However, an analysis of covariance (ANCOVA) adjusting for baseline values revealed no significant between-group differences in clinical and inflammatory parameters. The SNS group showed a significant increase in rMSSD (parasympathetic marker), with the between-group difference sustained after baseline adjustment. No significant differences were observed in functional and psychological scores or serum cytokine levels between the two groups. CONCLUSION: This first-in-human study indicates that percutaneous SNS is feasible and safe, with a possible modulatory effect on autonomic function in active RA. Further large‑scale, adequately powered trials are warranted to confirm the clinical efficacy and mechanisms of SNS in RA. TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov on March 25, 2021 under the identifier NCT04821050 (Protocol ID: 202002053). Key Points • First-in-human pilot study of percutaneous sacral nerve stimulation (SNS) in active RA. • SNS was associated with significant within-group improvements in tender joint count, pain VAS, and DAS28, but between-group differences did not reach statistical significance after baseline adjustment. • SNS significantly enhances parasympathetic activity (rMSSD) compared with sham stimulation, an effect that remained significant after adjusting for baseline differences. • Percutaneous SNS was safe and well-tolerated, with no serious adverse events reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAutonomic Nervous SystemLumbosacral PlexusAcupuncture TherapyHumansPilot ProjectsFemaleMiddle AgedMaleTreatment OutcomeAdultPain MeasurementAgedHeart RateSeverity of Illness Index

Stichwörter der Autor:innen

Autonomic nervous systemHeart rate variabilityNeuromodulationRheumatoid arthritisSacral nerve stimulation

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Traditional Chinese Medicine and Acupuncture, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Rheumatology and Immunology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. sudinglei@163.com.
  • Division of Gastroenterology and Hepatology, University of Michigan School of Medicine, Ann Arbor, MI, 48109, USA.

Förderung

  • International Cooperation Project of Nanjing Municipal Science and Technology Bureau

Zitieren

APA

Wang, X., Xu, B., Wang, G., Yang, L., Su, D., & Chen, J. D. Z. (2026). Sacral nerve stimulation modulates disease activity and autonomic function in active rheumatoid arthritis: a randomized pilot study. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08288-4

Vancouver

Wang X, Xu B, Wang G, Yang L, Su D, Chen JDZ. Sacral nerve stimulation modulates disease activity and autonomic function in active rheumatoid arthritis: a randomized pilot study. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08288-4

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoqin and Xu, Bingguo and Wang, Guoxin and Yang, Leilei and Su, Dinglei and Chen, Jiande D Z},
  title = {Sacral nerve stimulation modulates disease activity and autonomic function in active rheumatoid arthritis: a randomized pilot study},
  journal = {Clinical Rheumatology},
  year = {2026},
  doi = {10.1007/s10067-026-08288-4}
}
Kostenlos starten →